Who owns AN2 THERAPEUTICS INC?
- Ticker: ANTX
- CUSIP Number: 037326105
Tip: Access positions for across all investors
Analyze quarterly positions in An2 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of An2 Therapeutics stock
Who bought or sold AN2 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 5.6M | $18M | 0% | Mar 2024 |
|
| Citadel Advisors | 1.6M | $5.1M | 0% | Mar 2024 |
|
| Frazier Life Sciences Management | 1.4M | $4.5M | 0% | Mar 2024 |
|
| BVF | 1.2M | $4.0M | -21% | Mar 2024 |
|
| Henderson Group | 1.2M | $4.0M | -5% | Mar 2024 |
|
| Avidity Partners Management | 1.2M | $3.7M | 1% | Mar 2024 |
|
| Octagon Capital Advisors | 1.1M | $3.6M | 66% | Mar 2024 |
|
| Vanguard Group | 1.0M | $3.4M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 313k | $1.0M | -65% | Mar 2024 |
|
| BlackRock | 291k | $946k | 590% | Mar 2024 |
|
| Susquehanna International | 203k | $659k | 736% | Mar 2024 |
|
| Geode Capital Management | 179k | $583k | 100% | Mar 2024 |
|
| Acadian Asset Management | 164k | $529k | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 133k | $432k | 100% | Mar 2024 |
|
| Alyeska Investment Group | 100k | $325k | 100% | Mar 2024 |
|
| Nantahala Capital Management | 98k | $319k | -60% | Mar 2024 |
|
| Millennium Management | 97k | $315k | 144% | Mar 2024 |
|
| Two Sigma Investments | 94k | $306k | 389% | Mar 2024 |
|
| Marshall Wace | 83k | $268k | -76% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 76k | $248k | 100% | Mar 2024 |
|
| Citigroup | 71k | $230k | -56% | Mar 2024 |
|
| Jane Street | 59k | $192k | 0% | Mar 2024 |
|
| Qube Research & Technologies | 50k | $164k | 100% | Mar 2024 |
|
| Squarepoint Ops | 50k | $161k | 100% | Mar 2024 |
|
| RMB Capital Management | 46k | $941k | 0% | Dec 2023 |
|
| Laurion Capital Management | 44k | $142k | 0% | Mar 2024 |
|
| Springbok Capital Management | 40k | $131k | 100% | Mar 2024 |
|
| XTX Topco | 39k | $126k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 38k | $124k | 100% | Mar 2024 |
|
| Occudo Quantitative Strategies | 38k | $123k | 100% | Mar 2024 |
|
| Northern Trust | 36k | $118k | 119% | Mar 2024 |
|
| Captrust Financial Advisors | 29k | $93k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 28k | $92k | 102% | Mar 2024 |
|
| Barclays | 28k | $92k | -36% | Mar 2024 |
|
| Credit Suisse | 27k | $87k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 26k | $85k | -45% | Mar 2024 |
|
| Hrt Financial | 24k | $79k | 100% | Mar 2024 |
|
| Private Advisor | 23k | $73k | 100% | Mar 2024 |
|
| Chicago Partners Investment | 22k | $52k | 100% | Mar 2024 |
|
| Swiss National Bank | 21k | $67k | 100% | Mar 2024 |
|
| UBS Group | 20k | $64k | 100% | Mar 2024 |
|
| Bank of America Corporation | 15k | $49k | -32% | Mar 2024 |
|
| White Bay PT | 10k | $33k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 9.3k | $30k | 100% | Mar 2024 |
|
| Morgan Stanley | 4.2k | $14k | 50% | Mar 2024 |
|
| Tower Research Capital | 1.1k | $3.6k | -63% | Mar 2024 |
|
| Advisor Group Holdings | 300.00 | $975.000000 | 0% | Mar 2024 |
|
| Federated Investors | 258.00 | $5.3k | 163% | Dec 2023 |
|
| Rhumbline Advisers | 250.00 | $812.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 128.00 | $416.000000 | 2% | Mar 2024 |
|
Who sold out of An2 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Associates | Dec 2023 | 187k | $3.8M |
| Victory Capital Management | Dec 2023 | 52k | $1.1M |
| Deutsche Bank Aktiengesellschaft | Dec 2023 | 40k | $809k |
| Monashee Investment Management | Dec 2023 | 34k | $697k |
| TD Asset Management | Dec 2023 | 26k | $529k |
| Balyasny Asset Management | Dec 2023 | 19k | $395k |
| Man Group | Dec 2023 | 18k | $376k |
| Cubist Systematic Strategies | Dec 2023 | 17k | $338k |
| 683 Capital Management | Dec 2023 | 13k | $274k |
| FMR | Sep 2023 | 670.00 | $11k |
| Point72 Asia | Dec 2023 | 621.00 | $13k |